Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms

Saved in:

Bibliographic Details
Main Authors:	Leah A. Goldberg, James J. Yoon, Hannah Johnston, Marta B. Davidson, Alexa Siddon, Rory M. Shallis, Evan C. Chen, Madelyn Burkart, Timothy S. Oh, Sunil G. Iyer, Ellen Madarang, Chandrasekar Muthiah, Joshua Kassner, Raajit K. Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin Abaza, Jacqueline S. Garcia, Vikas Gupta, Kristen M. Pettit, Olatoyosi Odenike, John F. Cursio, Anand A. Patel
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Blood Neoplasia
Online Access:	http://www.sciencedirect.com/science/article/pii/S295032802500024X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
by: Reid Shaw, et al.
Published: (2025-05-01)

Letter to the editor concerning “effects of Levetiracetam and Lacosamide on survival and seizure control in 2IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy” by Andrea Bianconi et al
by: Karthikeyan Kandaswamy, et al.
Published: (2024-01-01)

Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
by: Samuel J. Yates, et al.
Published: (2025-07-01)

Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML
by: Justin Watts, et al.
Published: (2025-07-01)

Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
by: Daniel Krell, et al.
Published: (2011-01-01)

MYELODYSPLASTIC/MYELOPROLIFERATIVE DISEASES
by: I. N. Subortseva, et al.
Published: (2017-01-01)

Biology of Myeloproliferative Malignancies
by: AL Melikyan, et al.
Published: (2016-07-01)

GENETIC BIOMARKERS OF GLIAL BRAIN TUMORS: IDH1 AND IDH2 MUTATIONS
by: M. Yu. Prokudin, et al.
Published: (2020-09-01)

Disease characteristics and monitoring of IDH1/IDH2-mutated acute myeloid leukemia
by: Mélinda Dantec, et al.
Published: (2025-05-01)

Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment
by: Hurais Malik, et al.
Published: (2024-09-01)

Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial
by: Ruben A. Mesa, et al.
Published: (2013-06-01)

Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
by: Sylvie Hermouet, et al.
Published: (2015-01-01)

Unraveling the impact of lysosomal dysfunction on myeloproliferative neoplasm
by: Hyundong Yoon, et al.
Published: (2024-09-01)

Promising Findings in Myeloproliferative Neoplasms and AL Amyloidosis
by: Axel Rüfer
Published: (2022-10-01)

Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
by: Fabrizio Vianello, et al.
Published: (2011-01-01)

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
by: Holly L. Geyer, et al.
Published: (2015-01-01)

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia
by: Janne Austestad, et al.
Published: (2023-01-01)

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
by: Gregor Hoermann, et al.
Published: (2015-01-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Paola Guglielmelli, et al.
Published: (2010-05-01)

DIAGNOSIS AND ANALYSIS OF HYPER-TUNING DEEP LEARNING MODEL FOR AUTOMATIC DIAGNOSING CELIAC DISEASE
by: Sreenivas Pratapagiri, et al.
Published: (2025-03-01)

Unleashing immunity against oral cancer with immune checkpoint inhibitors
by: Ajay Guru
Published: (2024-06-01)

Characteristics of regional epidemiological indicators of chronic myeloproliferative neoplasms
by: O. Yu. Vinogradova, et al.
Published: (2025-05-01)

Failure of Splenectomy to Ameliorate Portal Hypertension in Myeloproliferative Disorders
by: Samuel S Lee, et al.
Published: (1994-01-01)

LANDSCAPE OF SOMATIC MUTATIONS OF MYELOPROLIFERATIVE NEOPLASMS IN PAKISTANI PATIENTS
by: Mehreen Ali Khan
Published: (2025-07-01)

Cerebrovascular Disorders Associated with Ph-Negative Myeloproliferative Diseases
by: MM Tanashyan, et al.
Published: (2019-09-01)

Pathogenesis and management of high molecular risk myeloproliferative neoplasms
by: Victoria Y. Ling, et al.
Published: (2024-12-01)

IDH1(R132H) Immunoexpression in Glioma
by: Nyan Saeed Omer, et al.
Published: (2023-03-01)

Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
by: Ying Pang, et al.
Published: (2025-04-01)

Metabolic reprogramming in mutant IDH1 glioma cells.
by: Jose L Izquierdo-Garcia, et al.
Published: (2015-01-01)

IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
by: Alexander Bray, et al.
Published: (2025-01-01)

Comparative Clinical-Imaging and Histogenetic Analysis Between Astrocytoma IDH-Mutant Grade 4 and Glioblastoma IDH-Wildtype—Is There Really a Worse One?
by: Cristian Ionut Orasanu, et al.
Published: (2025-02-01)

Myeloproliferative Disease: An Unusual Cause of Raynaud’s Phenomenon and Digital Ischaemia
by: Celia Beynon, et al.
Published: (2016-01-01)

Myeloid sarcoma of the larynx as manifestation of the terminal stage of myeloproliferative disease
by: A. L. Kozhanov, et al.
Published: (2023-06-01)

HMGB1 as a biomarker for myeloproliferative neoplasm complicated with atherosclerosis
by: Lunbi Wu, et al.
Published: (2025-05-01)

Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms
by: Linet Njue, et al.
Published: (2020-12-01)

Pro- and Antifibrotic Factors in the Serum of Patients with Chronic Myeloproliferative Disorders
by: AA Silyutina, et al.
Published: (2017-10-01)

IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
by: Kristian A. Choate, et al.
Published: (2024-10-01)

Mycobacterium shimoidei cavitary pneumonia: A rare case report, literature review
by: Siddartha Guru, et al.
Published: (2025-08-01)

Dependency-based fault diagnosis approach for SOA-based systems using Colored Petri Nets
by: Guru Prasad Bhandari, et al.
Published: (2022-02-01)

Optical control of ferroaxial order
by: Zhiren He, et al.
Published: (2024-12-01)